Ineos Inovyn to sell its stake in Italy’s Inovyn Produzione Italia (Rosignano, Tavazzano sites) to Esseco Industrial. Deal expected in 2026, pending approvals; operations and supply unchanged during transition.
Ghanaian start-up Ecovon produces coconut-husk boards as an alternative to MDF (medium-density fibreboard), made without intentionally added toxic chemicals.
Asahi Kasei has completed its acquisition of Germany’s Aicuris, adding three antiviral assets, in a deal previously reported at about €780 million.
Dow CEO Jim Fitterling will step down to become Executive Chair, while current COO Karen S. Carter has been appointed CEO effective July 1, 2026. The move follows a multi-year succession process.
Acquisition includes industry-leading ADC platform, its clinically-validated tubutecan linker-payload technology, and next-generation platform to expand Gilead’s ADC capabilities.
Colonial Chemical Solutions has acquired Integrity Partners Group, adding Chemisphere and Chemsolv to expand its Southeast footprint, capabilities, and customer reach in chemical distribution.
The specialty chemicals exhibition Chemspec Europe has released more details about its conference program - including key topics, session content and new interactive formats for 2026.
Certified alternative ethylene oxide (EO)-based ingredients enable customers to reduce Scope 3 greenhouse gas emissions while maintaining high performance standards.
DuPont has completed the sale of its Aramids business, including Kevlar and Nomex brands, to Arclin in a deal valued at about $1.8 billion.
Uhde Inventa-Fischer has signed a contract with Köksan for the supply of a PET production plant. The plant will be built in Yumurtalık, Türkiye.
CEFIC recently announced the promotion of Miguel Prieto Arranz to Executive Director, Specialty Chemicals, as of 1 April 2026.
Merck has launched its acquisition of Terns Pharmaceuticals, a deal valued at about $6.7 billion that would add to its hematology portfolio.
Ofichem has unified its six brands under the single Ofichem name, creating a fully integrated, family-owned CDMO and pharmaceutical supplier.
Providing technology expertise across chemical value chain sustainability projects.
Prange Pharma has completed its acquisition of MSD Animal Health’s Aprilia site in Italy, which will now operate as Aprilia Animal Health, a new European CDMO platform for the animal health sector.
BASF Agricultural Solutions recently completed the acquisition of AgBiTech. This follows the agreement signed in January 2026 with private equity firm Paine Schwartz Partners and other shareholders.
Adragos Pharma has acquired Sanofi’s Maisons-Alfort sterile fill-finish site in France, expanding its European manufacturing network and prefilled syringe capabilities.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
The newly constructed Verbund site in Zhanjiang, Guangdong Province in southern China, with an area of around four square kilometers, is more than just a major project for BASF in the growth market of China.
Connecting cost-advantaged production, technology leadership, access to global markets, and disciplined capital allocation to upgrade portfolio.
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
In this interview, industry experts explain why cell line development timelines are governed by biology—and how the focus is shifting from time compression to smarter optimization.
At CPhI Frankfurt, Christene Smith of CHEManager International interviews Axplora CCO Arul Ramadurai on navigating industry uncertainty and building strategic partnerships.
Kenyan start-up Zuripacks produces durable yet biodegradable packaging materials from banana pseudostems − an abundant agricultural by-product that is typically discarded.
The chemical industry's workforce is rapidly approaching retirement age. We need fresh talent, fast.
Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Ice Pharma recently announced a strategic expansion beyond its core API business, positioning the company to compete in higher-value finished dosage, nutraceutical, and specialty excipient markets.
First Clariant facility in the United States to manufacture pharmaceutical-grade polyethylene glycol excipients for oral and topical applications.
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
The Cleantech water technology company Blue Activity has completed an €8.5 million seed financing round.
“Enough with the Snail’s Pace!”: Industry Leaders Urge Action to Save Europe’s Chemical Sector
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
New $130 million facility in Jealott’s Hill, UK, to focus on next-generation, sustainable solutions for farming.
